Yasmin and Yaz Problems Highlighted by NY Times
An article in the New York Times over the weekend highlights the growing problems with Yaz and Yasmin birth control pills, which may have caused thousands of otherwise healthy young women to suffer serious and potentially life-threatening injuries, such as heart attacks, strokes, deep vein thrombosis (DVT), pulmonary embolism and gallbladder disease.
The Yaz and Yasmin lawyers at Saiontz & Kirk, P.A. are investigating potential lawsuits on behalf of women who have suffered from side effects of the top-selling birth control pills. In addition to Yaz lawsuits and Yasmin lawsuits, potential Ocella lawsuits are also being investigated for users of the generic version of the drug, which contains the same new progestin, drosperinone.
As the New York Times article points out, the claims allege that side effects of the birth control pills with drosperinone increase the risk of blood clots, even when compared to other available forms of birth control pills.
Bayer knew or should have known about the risks, and failed to adequately research their drugs or warn about the potential danger. In addition, misleading Yaz advertisements were directed at consumers to encourage them to take the drug, by making false and misleading statements. This may have exposed women to the risk of Yaz and Yasmin problems, such as:
If you, a friend or family member have experienced health problems from Yaz, Yasmin or Ocella, request a free consultation and claim evaluation.
